Literature DB >> 6331899

Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate.

L K Ashman.   

Abstract

The mitogenicity of 12-O-tetradecanoyl phorbol-13-acetate (TPA) for normal human peripheral blood mononuclear cells was investigated. TPA was a weak mitogen giving simulation indices in the range 2.5 to 10.5 at the optimum concentration (10 ng/ml) compared with 39 to 95 for phytohemagglutinin (PHA) at its optimum concentration (1 microgram/ml). No absolute requirement for a comitogen could be demonstrated, however TPA and PHA were synergistic in their action at low concentrations, and additive at optimum concentrations. Cell fractionation by rosetting with sheep erythrocytes showed that most of the proliferative response to TPA occurred in the T-cell fraction, however some proliferation of non-T cells was also observed. Surface marker studies showed that this could not have been due to residual T cells in the non-T fraction. A small number of monocytes was required for optimal proliferation of T cells in response to TPA. After a 3-day incubation with mitogen, the responding cell populations were tested for binding of a range of antibodies specific for T-cell (OKT3, OKT4, OKT8, and OKT11), "natural killer" (NK) cell (anti-Leu-7), monocyte (FMC17), and B-cell (anti-human immunoglobulin) surface markers. These experiments indicated that the responding cell types were T cells and B cells, but not NK cells or monocytes. Marked modulation of the antigen detected by OKT4, and to a lesser extent that detected by OKT3, in the presence of TPA precluded determination of which subpopulations of T cells proliferated in response to TPA. TPA was also tested for its ability to "maintain" activated T-cell blasts in a standard assay for interleukin 2 (IL-2). Mitogen-activated T cells were strongly responsive to TPA in this assay, but progressively lost responsiveness when maintained in crude IL-2 for about 2 weeks. Thus TPA does not have "maintenance" (i.e., IL-2-like) activity. However, small amounts of TPA acted synergistically with PHA in maintaining blast populations which were not responsive to TPA alone. This illustrates the importance of using long term IL-2-dependent cell lines for quantitation of IL-2 in supernatants prepared by stimulating T cells with these agents.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331899     DOI: 10.1016/0008-8749(84)90029-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

Authors:  L K Ashman; G W Kriek; S J Cooper; D E O'Keefe
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Translocation of phospholipid/Ca2+-dependent protein kinase in B-lymphocytes activated by phorbol ester or cross-linking of membrane immunoglobulin.

Authors:  A E Nel; M W Wooten; G E Landreth; P J Goldschmidt-Clermont; H C Stevenson; P J Miller; R M Galbraith
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

3.  C-kinase activity in normal B cells treated with Staphylococcus aureus, Cowan strain I, and phorbol ester: response differences in a patient with prolymphocytic leukaemia.

Authors:  R Cooper; J Louw; J Daniels; D P de Beer; A E Nel
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

4.  Characterization of mouse thymocyte subpopulations by the enzymatic marker 20-alpha-hydroxysteroid dehydrogenase: differential responses to IL-1 and IL-2.

Authors:  E Aflalo; R Ofir; R N Apte; Y Weinstein
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

5.  Cholera toxin partially inhibits the T-cell response to phytohaemagglutinin through the ADP-ribosylation of a 45 kDa membrane protein.

Authors:  A E Nel; M Vandenplas; M M Wooten; R Cooper; S Vandenplas; A Rheeder; J Daniels
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.